Express Scripts

Most Recent

  • uploads///Graph Part  Nov
    Company & Industry Overviews

    Express Scripts Trades Above Its 100-Day Moving Average

    Express Scripts Holdings rose 0.4%. The company was in the news on November 10 when it announced that it would remove Linden Care Pharmacy from its network.

    By Peter Neil
  • uploads///family _
    Company & Industry Overviews

    UNH’s Stock Price Performance in June

    On June 28, UnitedHealth Group (UNH) ended the trading day at $244.90, ~4.6% lower than its 52-week low of $183.86 reached on July 18, 2017.

    By Sarah Collins
  • How to Invest in Global Wide Moat Stocks
    Consumer

    How to Invest in Global Wide Moat Stocks

    The Morningstar Global Wide Moat Focus Index has global exposure, unlike the Morningstar International Moat Index (MOTI).

    By VanEck
  • uploads///BUSINESS POSITIONING
    Earnings Report

    How Is UNH’s Optum Business Positioned in the Industry?

    UnitedHealth Group is, by revenue, the largest healthcare company in the world.

    By Sarah Collins
  • uploads///trump tower _
    Consumer

    Drugstore Stocks Tumble ahead of Trump’s New Drug Policy

    The stocks of top drugstore chains CVS Health (CVS) and Walgreens Boots Alliance (WBA) were down yesterday amid ongoing tensions regarding a policy change in US drug pricing.

    By Sonya Bells
  • uploads///LHC
    Company & Industry Overviews

    What’s LHC Group’s Business Strategy?

    In 2018, LHC Group is expected to report revenue of $1.2 billion. What about its peers?

    By Kenneth Smith
  • uploads///hospice _
    Company & Industry Overviews

    What Analysts Recommend for Civitas Solutions in March 2018

    Of the four analysts covering Civitas Solutions, two analysts have given the stock a “strong buy” rating, and two analysts have given it a “buy” rating.

    By Kenneth Smith
  • uploads///hands _
    Healthcare

    Cigna Expects Acquisition of Express Scripts by End of 2018

    On March 7, 2018, Cigna (CI) announced that it has entered into a definitive agreement to acquire Express Scripts (ESRX) for $67 billion.

    By Margaret Patrick
  • uploads///doctors office checkup medical
    Company & Industry Overviews

    Analysts’ Ratings for AmerisourceBergen in March 2018

    Four analysts gave AmerisourceBergen stock a “strong buy” rating, seven analysts gave it a “buy” rating, and seven analysts gave it a “hold” rating.

    By Kenneth Smith
  • uploads///ABC
    Company & Industry Overviews

    Analyzing AmerisourceBergen’s Recent Acquisitions

    In December 2017, AmerisourceBergen (ABC) acquired Northeast Supply Company, or NEVSCO, for a consideration of $70 million.

    By Kenneth Smith
  • uploads///REV EPS GROWTH ESRX
    Miscellaneous

    Express Scripts: How Its Performance Contributed to Its Valuation

    Express Scripts’ (ESRX) revenue fell 1% in both 2016 and the first nine months of 2017.

    By Amanda Lawrence
  • uploads///NET SALES EPS GROWTH MYL
    Consumer

    Mylan: How Its Performance Contributed to Its Valuation

    In this final series of our three-part series, we’ll be looking at the last seven stocks among the top 18 cheap stocks in the S&P 500 for 2018.

    By Amanda Lawrence
  • uploads///a
    Company & Industry Overviews

    Walgreens versus CVS: Discussing PBM Strategies

    In August 2016, Walgreens announced a long-term strategic alliance with Prime Therapeutics, America’s fourth-largest PBM.

    By Sonya Bells
  • uploads///Graph
    Company & Industry Overviews

    Patient Recovery Acquisition May Boost Cardinal Health’s Revenues

    On July 30, 2017, Cardinal Health (CAH) completed the acquisition of Medtronic’s patient recovery business for an all-cash consideration worth $6.1 billion.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Robust Growth Expected for Cardinal Health’s Specialty Solutions

    Cardinal Health’s (CAH) Specialty Solutions segment provides two types of services: upstream to pharmaceutical and biopharmaceutical manufacturers and downstream to healthcare providers.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Cardinal Health: Stable Net Profit Margins in Fiscal 2018?

    Wall Street analysts have projected Cardinal Health’s fiscal 2018 net profit margins to be 1.0%, which will be similar to what the company reported in fiscal 2017.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Cardinal Health Expected to Report Modest Revenue Growth

    For fiscal 2018, Cardinal Health (CAH) has projected mid-single-digit revenue growth on a YoY basis, partially driven by the company’s high customer retention rates.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Eosinophilic Esophagitis: Major Market Opportunity for Dupixent?

    Regeneron (REGN) has obtained positive results from its Phase 2 proof-of-concept study evaluating Dupixent in eosinophilic esophagitis.

    By Margaret Patrick
  • uploads///part
    Company & Industry Overviews

    How 3M Company’s Products Look After Your Health

    Revenues from 3M Company’s (MMM) Healthcare segment rose from 16.7% ($5 billion) of total annual revenue in 2011 to 17.5% ($5.4 billion) in 2015.

    By Shannon Black
  • uploads///Part
    Earnings Report

    Drivers That Impact CVS’s Pharmacy Services Segment

    CVS Health (CVS) is projecting 2Q15 revenue growth between 11.25% and 12.5% for its Pharmacy Services, which provides pharmacy benefit management (or PBM) services.

    By Phalguni Soni
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.